FemSelect is a developer of medical devices designed to treat pelvic organ prolapse disease in women. The company's devices offer a minimally-invasive surgical system for suturing ligaments of the pelvic floor without overnight hospital stays and scars, enabling physicians to conduct surgery without dissection or mesh.

Investment: Series B (Lead)